Comparison of estrogen-derived ortho-quinone and para-quinol concerning induction of oxidative stress

Journal of Steroid Biochemistry and Molecular Biology

Volumn 105, Issue 1-5, 2007, Pages 71-75

  Rivera Portalatin, Nilka M ^a   Vera Serrano, José L ^b   Prokai Tatrai, Katalin ^b   Prokai, Laszlo ^a,b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Estrogen metabolite; Oxidative stress; Redox cycling; Reductive aromatization

Indexed keywords

10BETA,17BETA DIHYDROXYESTRA 1,4 DIEN 3 ONE; CATECHOL ESTROGEN; ESTROGEN; ESTRONE 3,4 QUINONE; HYDROXYL RADICAL; PARA QUINOL; QUINONE DERIVATIVE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AROMATIZATION; ARTICLE; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMALE; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RAT; UTERUS;

BENZOQUINONES; CHROMATOGRAPHY, LIQUID; ESTROGENS; HYDROQUINONES; OXIDATIVE STRESS; TANDEM MASS SPECTROMETRY;

EID: 34547687410     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.11.025     Document Type: Article

References (37)

1. Behl C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 3 (2002) 433-442
2. Prokai L., Prokai-Tatrai K., Perjesi P., and Simpkins J.W. Mechanistic insights into the direct antioxidant effects of estrogens. Drug Dev. Res. 66 (2006) 118-125
3. Tsuchiya Y., Nakayima M., and Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett. 227 (2005) 115-124
4. Liehr J.G., and Roy D. Free radical generation by redox cycling of estrogen. Free Rad. Biol. Med. 8 (1990) 415-432
5. Zhu B.T., and Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 (1998) 1-27
6. Bolton J.L. Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens. Toxicology 177 (2002) 55-65
7. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., and Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 13 (2000) 135-160
8. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., and Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10937-10942
9. Ohe T., Hirobe M., and Mashino T. Novel metabolic pathway of estrone and 17β-estradiol catalyzed by cytochrome P-450. Drug Metab. Dispos. 28 (2000) 110-112
10. Prokai L., Prokai-Tatrai K., Perjesi P., Zharikova A.D., Perez E.J., Liu R., and Simpkins J. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 11741-11746
11. Prokai L., Prokai-Tatrai K., Perjesi P., Zharikova A.D., and Simpkins J.W. Quinol-based metabolic cycle for estrogens in rat liver microsomes. Drug Metab. Dispos. 31 (2003) 701-704
12. Nutter L.M., Wu Y.-Y., Ngo E.O., Sierra E.E., Gutierrez P.L., and Abul-Hajj Y.J. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem. Res. Toxicol. 7 (1994) 23-28
13. Corless J.K., and Middleton H.M. Normal liver function: a basis for understanding hepatic disease. Arch. Intern. Med. 143 (1983) 2291-2294
14. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59 (1992) 1609-1623
15. Halliwell B. Role of free radicals in the neurodegenerative diseases-therapeutic implications for antioxidant treatment. Drugs Aging 18 (2001) 685-716
16. Ohia S.E., Opere C.A., and LeDay A.M. Pharmacological consequences of oxidative stress in ocular tissues. Mutat. Res. 579 (2005) 22-36
17. Jain S., Saxena D., Kumar P.G., Koide S.S., and Laloraya M. Effect of estradiol and selected antiestrogens on pro- and antioxidant pathways in mammalian uterus. Contraception 60 (1999) 111-118
18. Gomez-Zubeldia M.A., Corrales S., Arbues J., Nogales A.G., and Millan J.C. Influence of estradiol and gestagens on oxidative stress in the rat uterus. Gynecol. Oncol. 86 (2002) 250-258
19. Abul-Hajj Y.J. Synthesis of 3,4-estrogen-o-quinone. J. Steroid Biochem. 21 (1984) 621-622
20. Šolaja B.A., Milić D.R., and Gašić M.J. A novel m-CPBA oxidation: p-quinols and epoxyquinols from phenols. Tetrahedron Lett. 37 (1996) 3765-3768
21. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
22. Liehr J.G., Fang W.F., Sirbasku D.A., and Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24 (1986) 353-356
23. Li J.J., and Li S.A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc. 46 (1987) 1858-1863
24. Newbold R.R., and Lehr J.G. Induction of uterine carcinoma in CD-1 mice by catechol estrogens. Cancer Res. 60 (2000) 235-237
25. Patel M.M., and Bhat H.H. Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: involvement of metabolic activation and cytochrome P450. J. Biochem. Mol. Toxicol. 18 (2004) 37-42
26. Liehr J.G., Uluben A.A., and Strobel H.W. Cytochrome P-450-mediated redox cycling of estrogens. J. Biol. Chem. 261 (1986) 16865-16870
27. Iverson S.L., Shen L., Anlar N., and Bolton J.L. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res. Toxicol. 9 (1996) 492-499
28. Stack D.E. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9 (1996) 851-859
29. Cavalieri E.L., Li K.M., Balu N., Saeed M., Devanesan P., Higginbotham S., Zhao J., Gross M.L., and Rogan E.G. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 23 (2002) 1071-1077
30. Chakravarti D., Mailander P.C., Li K.M., Higginbotham S., Zhang H.L., Gross M.L., Meza J.L., Cavalieri E.L., and Rogan E.G. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20 (2001) 7945-7953
31. Moosmann B., and Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 8867-8872
32. Toung T.J., Traytsman R.J., and Hurn P.D. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29 (1998) 1666-1670
33. Yang S.H., Shi J., Day A.L., and Simpkins J.W. Estradiol excerts neuroprotective effects when administered after ischemic insult. Stroke 31 (2000) 745-749
34. Liu R., Yang S.-H., Perez E., Yi K.D., Wu S.S., Eberst K., Prokai L., Prokai-Tatrai K., Cai Z.Y., Covey D.F., Day A., and Simpkins J.W. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke 33 (2002) 2485-2491
35. Green P.S., and Simpkins J.W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18 (2000) 347-358
36. Green P.S., Gordon K., Simpkins J.W., and Phenolic. A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 63 (1997) 229-235
37. Prokai L., Oon S.M., Prokai-Tatrai K., Abboud K.A., and Simpkins J.W. Synthesis and biological evaluation of 17β-alkoxyestra-1,3,5(10)-trienes as potential neuroprotectants against oxidative stress. J. Med. Chem. 44 (2001) 110-114